171 related articles for article (PubMed ID: 1667783)
1. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
Wise R; Johnson J; O'Sullivan N; Andrews JM; Imbimbo BP
J Antimicrob Chemother; 1991 Dec; 28(6):905-9. PubMed ID: 1667783
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
Mattina R; Bonfiglio G; Cocuzza CE; Gulisano G; Cesana M; Imbimbo BP
Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
[TBL] [Abstract][Full Text] [Related]
3. Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
Kisicki JC; Griess RS; Ott CL; Cohen GM; McCormack RJ; Troetel WM; Imbimbo BP
Antimicrob Agents Chemother; 1992 Jun; 36(6):1296-301. PubMed ID: 1329618
[TBL] [Abstract][Full Text] [Related]
4. Inter- and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers.
Imbimbo BP; Broccali G; Cesana M; Crema F; Attardo-Parrinello G
Antimicrob Agents Chemother; 1991 Feb; 35(2):390-3. PubMed ID: 2024974
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of rufloxacin once daily in patients with lower respiratory tract infections.
Rimoldi R; Fioretti M; Albrici A; Imbimbo BP
Infection; 1992; 20(2):89-93. PubMed ID: 1316313
[TBL] [Abstract][Full Text] [Related]
6. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
Triger DR; Granai F; Woodcock J; Wise R; Imbimbo BP
Hepatology; 1993 Oct; 18(4):847-52. PubMed ID: 8406358
[TBL] [Abstract][Full Text] [Related]
7. Biliary excretion of rufloxacin in humans.
Privitera G; Nicastro G; Imbimbo BP; Cesana M; Visconti M; Lombardi F; Tagliabue G; Faleschini E; Colturani F; Franzini P
Antimicrob Agents Chemother; 1993 Dec; 37(12):2545-9. PubMed ID: 8109915
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of rufloxacin in healthy volunteers.
Segre G; Cerretani D; Moltoni L; Urso R
Eur J Clin Pharmacol; 1992; 42(1):101-5. PubMed ID: 1311685
[TBL] [Abstract][Full Text] [Related]
9. Ocular pharmacokinetics of rufloxacin a new fluoroquinolone antibiotic.
Nucci P; Lombardo N; Cremonesi F; Manitto MP; Brancato R; Ghione M
Clin Ter; 1992 Jun; 140(6):563-7. PubMed ID: 1322259
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
[TBL] [Abstract][Full Text] [Related]
11. Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin.
Lazzaroni M; Imbimbo BP; Bargiggia S; Sangaletti O; Dal Bo L; Broccali G; Bianchi Porro G
Antimicrob Agents Chemother; 1993 Oct; 37(10):2212-6. PubMed ID: 8257146
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.
Gee T; Andrews JM; Ashby JP; Marshall G; Wise R
J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415
[TBL] [Abstract][Full Text] [Related]
14. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
[TBL] [Abstract][Full Text] [Related]
15. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 1-(5-fluoro-2-pyridyl)-6-fluoro-7-(4-methyl-1- piperazinyl)-1,4-dihydro-4-oxoquinolone-3-carboxylic acid hydrochloride (DW-116), a new quinolone antibiotic in rats.
Yu IL; Chung SJ; Lee MH; Shim CK
J Pharm Sci; 1997 May; 86(5):550-3. PubMed ID: 9145377
[TBL] [Abstract][Full Text] [Related]
17. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
[TBL] [Abstract][Full Text] [Related]
19. Penetration of rufloxacin into human prostatic tissue and fluid.
Boerema JB; Bach D; Jol C; Pahlmann W
J Antimicrob Chemother; 1991 Oct; 28(4):547-54. PubMed ID: 1662190
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of rufloxacin in patients with impaired renal function.
Perry G; Mant TG; Morrison PJ; Sacks S; Woodcook J; Wise R; Imbimbo BP
Antimicrob Agents Chemother; 1993 Apr; 37(4):637-41. PubMed ID: 8388194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
